BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35772685)

  • 1. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
    Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
    Dana J; Girard M; Franchi-Abella S; Berteloot L; Benoit-Cherifi M; Imbert-Bismut F; Sermet-Gaudelus I; Debray D
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101855. PubMed ID: 34933150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
    Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
    PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
    Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study.
    Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.
    Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK
    J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    Klotter V; Gunchick C; Siemers E; Rath T; Hudel H; Naehrlich L; Roderfeld M; Roeb E
    PLoS One; 2017; 12(6):e0178784. PubMed ID: 28575039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modifiers of liver disease in cystic fibrosis.
    Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
    JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
    Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP
    Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D Shear Wave Elastography, a promising screening tool for Cystic Fibrosis liver disease, shows a correlation between vitamin D and liver stiffness.
    H E; Cr H; S D; Ea E
    J Cyst Fibros; 2022 Sep; 21(5):873-877. PubMed ID: 35794060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Screening for Cystic Fibrosis-related Liver Disease Including Elastography in Children and Adolescents.
    Højte C; Jørgensen MH; Jensen F; Katzenstein TL; Skov M
    J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):663-668. PubMed ID: 33093375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.